case report aspiration during anesthesia glp-1 receptor agonist 2023 Low Incidence of Pulmonary Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 It's not because the GLP-1

There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial

Finally, GLP-1s slow down digestion, changing the way a person's body turns food into energy

Yang Y, Zhou Y, Wang Y, Wei X, Wang T, Ma A

LEAN Trial: Liraglutide and NASH resolution The pioneering LEAN (Liraglutide Safety and Efficacy in patients with Non-alcoholic steatohepatitis) trial marked the first rigorous evaluation of GLP-1 agonists for NASH treatment

After 52 weeks of treatment with liraglutide, healthy obese women experienced serum P1NP level increases of 16% on average (31)

NCT06555640)